Top Regulatory News Stories – Week Ending February 16, 2018
This week was saw the approval of two new molecular entities by the FDA while Apricus received a Complete Response Letter. Here is my recap of the top regulatory news stories for this week… Vertex Pharmaceuticals’ Symdeko (tezacaftor/ivacaftor and ivacaftor) has been approved by the FDA to treat the underlying cause of cystic[…]